Radcliffe Cardiology, Jordan Rance; Special Editor: Greg Guillory

Broadcast

Ags test webinar for pigeon hole demo DO NOT USE

Javier Escaned,

Watch time: 47m 14s

About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Articles

Drug-eluting Stent Utilisation and Outcomes in Acute Coronary Syndromes : Evidence-based Practice Without the Evidence?

Citation:

Interventional Cardiology 2006;1(1):33-4

Drug-eluting Stents - Current and Future Perspectives

Citation:

Interventional Cardiology 2006;1(1):28-9

EPS in TAVI Patients

Published:

01 June 2020

Citation:

Arrhythmia & Electrophysiology Review 2020;9(1):20–7.